CytoSorbents Corporation (CTSO)

[Bikle]

By and large I agree with you.

Kathleen Bloch (CFO Cytosorbents) told us, during last CC, when on a major stock exchange there are favourable circumstances that would spark investors to buy more easily. I can imagine it's more difficult to buy or sell OTC stocks when really large amount of shares are involved in a trade, but apart from that I see no obstacles. Cytosorbents has already 'big' investors on board (at 0.25 cents), and they have to be patient now.

I think there is a paradoxical situation that is parking Cytosorbents. They are in need of partners to drive solid trials in order to deliver the clinical data. But potential partners say, well we are hesitant to partner because you do not have even rudimentary clinical data. We don't know were we stand.